头颈部鳞癌瘤内异质性具有生物标志物特异性,多模态功能成像的关联受到挑战
结果显示多数免疫组化标志物存在显著异质性,但仅GLUT1与p53之间及Ki-67与EGFR之间存在相关性,功能成像异质性与部分免疫组化标志物仅呈弱关联,提示生物学异质性取决于具体标志物或成像模态,而非普遍性肿瘤特征。
要点
- 多数免疫组化标志物存在显著瘤内异质性,尤其GLUT1、PD-L1、Ki-67、CAIX和p53。
- FDG摄取与扩散异质性与细胞密度异质性相关。
- 功能成像异质性与免疫组化标志物异质性关联弱且仅见于少数标志物。
核心结论
- 头颈鳞癌瘤内免疫组化标志物异质性显著,但标志物之间相关性少且弱,功能成像与部分免疫组化标志物异质性仅呈弱关联。
- 生物学异质性并非肿瘤的普遍特征,而是取决于具体生物标志物或成像模态。
研究设计与样本
- 肿瘤整块切除后取6个核心活检,对p40、p53、EGFR、Ki-67、GLUT1、VEGF、Bcl-2、CAIX、PD-L1行免疫组化染色。
- 以6个核心活检肿瘤比例评分的变异系数(CV)量化每个免疫组化标志物的瘤内异质性。
- 以18F-FDG摄取、扩散和灌注的变异系数(CV)评估成像生物标志物异质性,采用Spearman秩相关量化两种方差度量的一致性。
诊断标准与关键数值
- 瘤内免疫组化异质性以6个核心活检肿瘤比例评分的变异系数(CV)量化。
- 成像异质性以18F-FDG摄取、扩散和灌注的变异系数(CV)量化。
- GLUT1与p53之间、Ki-67与EGFR之间观察到异质性相关。
- FDG摄取和扩散的异质性与细胞密度异质性相关。
临床应用与阅片要点
- 阅片时需认识到功能成像异质性与分子生物标志物异质性并非一一对应,不能仅凭影像异质性推断特定分子表型。
- FDG摄取和扩散异质性可反映细胞密度异质性,可作为细胞密度不均的间接影像线索。
- 多模态功能成像参数(FDG摄取、扩散、灌注)的异质性分析应结合具体生物标志物解读,避免泛化结论。
局限性
- 仅取6个核心活检评估免疫组化异质性,可能低估或代表不全肿瘤整体异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE: Tumor biopsy cannot detect heterogeneity and an association between heterogeneity in functional imaging and molecular biology will have an impact on both diagnostics and treatment possibilities.
PURPOSE: Multiparametric imaging can provide 3D information on functional aspects of a tumor and may be suitable for predicting intratumor heterogeneity. Here, we investigate the correlation between intratumor heterogeneity assessed with multiparametric imaging and multiple-biopsy immunohistochemistry.
METHODS: In this prospective study, patients with primary or recurrent head and neck squamous cell carcinoma (HNSCC) underwent PET/MRI scanning prior to surgery. Tumors were removed en bloc and six core biopsies were used for immunohistochemical (IHC) staining with a predefined list of biomarkers: p40, p53, EGFR, Ki-67, GLUT1, VEGF, Bcl-2, CAIX, PD-L1. Intratumor heterogeneity of each IHC biomarker was quantified by calculating the coefficient of variation (CV) in tumor proportion score among the six core biopsies within each tumor lesion. The heterogeneity in the imaging biomarkers was assessed by calculating CV in 18F-fluorodeoxyglucose (FDG)-uptake, diffusion and perfusion. Concordance of the two variance measures was quantified using Spearman's rank correlation RESULTS: Twenty-eight patients with a total of 33 lesions were included. There was considerable heterogeneity in most of the IHC biomarkers especially in GLUT1, PD-L1, Ki-67, CAIX and p53, however we only observed a correlation between the heterogeneity in GLUT1 and p53 and between Ki-67 and EGFR. Heterogeneity in FDG uptake and diffusion correlated with heterogeneity in cell density.
CONCLUSION: Considerable heterogeneity of IHC biomarkers was found, however, only few and weak correlations between the studied IHC markers were observed. The studied functional imaging biomarkers showed weak associations with heterogeneity in some of the IHC biomarkers. Thus, biological heterogeneity is not a general tumor characteristic but depends on the specific biomarker or imaging modality.
引用
- Rasmussen JH, Olin AB, Lelkaitis G, et al. Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma. Eur J Radiol. 2021. PMID: 33848777. doi:10.1016/j.ejrad.2021.109668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。